Charles Schwab’s Tonix Pharmaceuticals TNXP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $782K | Buy |
+21,732
| New | +$782K | ﹤0.01% | 2980 |
|
|
2022
Q2 | – | Sell |
-1,248,831
| Closed | -$288K | – | 3640 |
|
|
2022
Q1 | $288K | Buy |
1,248,831
+161,099
| +15% | +$37.2K | ﹤0.01% | 3222 |
|
|
2021
Q4 | $390K | Buy |
1,087,732
+205,998
| +23% | +$73.9K | ﹤0.01% | 3227 |
|
|
2021
Q3 | $531K | Buy |
881,734
+62,865
| +8% | +$37.9K | ﹤0.01% | 3126 |
|
|
2021
Q2 | $909K | Buy |
818,869
+692,597
| +548% | +$769K | ﹤0.01% | 2967 |
|
|
2021
Q1 | $162K | Buy |
126,272
+35,175
| +39% | +$45.1K | ﹤0.01% | 3341 |
|
|
2020
Q4 | $62K | Hold |
91,097
| – | – | ﹤0.01% | 3343 |
|
|
2020
Q3 | $77K | Buy |
+91,097
| New | +$77K | ﹤0.01% | 3258 |
|